TNDM Stock - Tandem Diabetes Care, Inc.
Unlock GoAI Insights for TNDM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $940.20M | $747.72M | $801.22M | $702.80M | $498.83M |
| Gross Profit | $489.57M | $367.69M | $412.99M | $376.21M | $260.52M |
| Gross Margin | 52.1% | 49.2% | 51.5% | 53.5% | 52.2% |
| Operating Income | $-99,127,000 | $-233,230,000 | $-92,848,000 | $22.65M | $-7,957,000 |
| Net Income | $-96,025,000 | $-222,611,000 | $-94,594,000 | $15.57M | $-34,382,000 |
| Net Margin | -10.2% | -29.8% | -11.8% | 2.2% | -6.9% |
| EPS | $-1.47 | $-3.43 | $-1.47 | $0.25 | $-0.56 |
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Visit WebsiteEarnings History & Surprises
TNDMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.31 | $-0.31 | 0.0% | = MET |
Q3 2025 | Aug 6, 2025 | $-0.40 | $-0.48 | -20.0% | ✗ MISS |
Q2 2025 | Apr 30, 2025 | $-0.60 | $-0.67 | -11.7% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $-0.25 | $-0.44 | -76.0% | ✗ MISS |
Q4 2024 | Nov 6, 2024 | $-0.43 | $-0.36 | +16.3% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $-0.54 | $-0.47 | +13.0% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $-0.80 | $-0.63 | +21.3% | ✓ BEAT |
Q1 2024 | Feb 21, 2024 | $-0.23 | $-0.27 | -17.4% | ✗ MISS |
Q4 2023 | Nov 1, 2023 | $-0.35 | $-0.38 | -8.6% | ✗ MISS |
Q3 2023 | Aug 3, 2023 | $-0.54 | $-0.30 | +44.4% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $-0.56 | $-0.63 | -12.5% | ✗ MISS |
Q1 2023 | Feb 22, 2023 | $-0.00 | $-0.01 | -338.6% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $-0.05 | $-0.27 | -455.3% | ✗ MISS |
Q3 2022 | Aug 3, 2022 | $-0.02 | $-0.24 | -1460.5% | ✗ MISS |
Q2 2022 | May 4, 2022 | $-0.07 | $-0.23 | -228.6% | ✗ MISS |
Q1 2022 | Feb 22, 2022 | $0.21 | $0.16 | -23.8% | ✗ MISS |
Q4 2021 | Nov 3, 2021 | $0.06 | $0.09 | +50.0% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $-0.08 | $0.06 | +175.0% | ✓ BEAT |
Latest News
Frequently Asked Questions about TNDM
What is TNDM's current stock price?
What is the analyst price target for TNDM?
What sector is Tandem Diabetes Care, Inc. in?
What is TNDM's market cap?
Does TNDM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TNDM for comparison